| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db8acd71f5994544bda6df3f27a3f51e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-84 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-067 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dbff6e196fd7c87dc6469b996921443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc239b2dfcf0beeba3bc97962a50332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016b48cf11d3013b7ddd6107b2737ef9 |
| publicationDate |
2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150048868-A |
| titleOfInvention |
Methods for producing cells having a phenotype of a primary human hepatocytes and compositions |
| abstract |
The present disclosure provides methods and compositions relating to in vitro cultures of human hepatocellular cell lines expressing a primary human hepatocyte phenotype. Such cell lines are sensitive to infection by hepatitis B virus, such as HCV or HBV, and support both viral replication and high level viral particle production. Such in vitro cultures provide for the generation and study of hepatitis viruses and also for screening methods (e.g., methods for evaluating drug metabolism for antiviral drugs) and for the study of primary human hepatocytes do. |
| priorityDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |